|
CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
|
US4304777A
(en)
|
1979-08-30 |
1981-12-08 |
Sterling Drug Inc. |
6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
|
|
US4305943A
(en)
|
1980-04-28 |
1981-12-15 |
Sterling Drug Inc. |
4-Amino-6-(pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
|
|
US4943533A
(en)
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
|
US4826835A
(en)
|
1985-10-23 |
1989-05-02 |
Rorer Pharmaceutical Corporation |
Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
|
|
WO1989008108A1
(en)
|
1988-02-23 |
1989-09-08 |
Rorer International (Overseas) Inc. |
Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
|
|
EP0491007B1
(en)
|
1989-09-08 |
1996-03-13 |
The Johns Hopkins University |
Structural alterations of the egf receptor gene in human gliomas
|
|
DE4127404A1
(de)
|
1991-08-19 |
1993-02-25 |
Thomae Gmbh Dr K |
Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
US5679683A
(en)
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
ES2167391T3
(es)
|
1994-09-16 |
2002-05-16 |
Merck Patent Gmbh |
Inmunoconjugados ii.
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
MX9800215A
(es)
|
1995-07-06 |
1998-03-31 |
Novartis Ag |
Pirrolopirimidas y procesos para su preparacion.
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
|
HU228446B1
(en)
|
1996-04-12 |
2013-03-28 |
Warner Lambert Co |
Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof
|
|
ID19609A
(id)
|
1996-07-13 |
1998-07-23 |
Glaxo Group Ltd |
Senyawa-senyawa heterosiklik
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
WO2000031048A1
(en)
|
1998-11-19 |
2000-06-02 |
Warner-Lambert Company |
N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
|
|
ATE446366T1
(de)
|
2000-06-22 |
2009-11-15 |
Genentech Inc |
Agonistische monoklonale antikörper gegen trkc
|
|
US20040067955A1
(en)
|
2002-09-06 |
2004-04-08 |
Fujisawa Pharmaceutical Co. Ltd. |
Pyridazinone compound and pharmaceutical use thereof
|
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
|
CN1938296A
(zh)
|
2004-04-01 |
2007-03-28 |
安斯泰来制药有限公司 |
作为腺苷拮抗剂的吡嗪衍生物及其制药用途
|
|
US7696352B2
(en)
|
2004-06-18 |
2010-04-13 |
Millennium Pharmaceuticals, Inc. |
Factor Xa inhibitors
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
JP2008521806A
(ja)
|
2004-11-30 |
2008-06-26 |
アーテシアン セラピューティクス， インコーポレイテッド |
心不全を治療するための混合型のＰＤＥ−阻害活性およびβ−アドレナリン作用性アンタゴニスト活性または部分アゴニスト活性を有する化合物
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
EP1899323A2
(en)
|
2005-05-16 |
2008-03-19 |
AstraZeneca AB |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
CN102206216B
(zh)
|
2005-06-22 |
2014-11-12 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
|
EP1919979B2
(en)
|
2005-08-25 |
2017-03-29 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of k-252a and derivatives thereof
|
|
EP2455382B1
(en)
|
2005-12-13 |
2016-10-26 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
AU2006325746A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
ZA200808966B
(en)
|
2006-03-27 |
2010-03-31 |
Nerviano Medical Sciences Srl |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
|
US20110008347A1
(en)
|
2006-12-01 |
2011-01-13 |
Agency For Science ,Technology And Research |
Cancer-related protein kinases
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
PE20081581A1
(es)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
AU2007336811A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US20130012485A1
(en)
|
2006-12-22 |
2013-01-10 |
Baeschlin Daniel Kaspar |
Organic compounds
|
|
WO2008078091A1
(en)
|
2006-12-22 |
2008-07-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
|
EP2152688A1
(en)
|
2007-05-04 |
2010-02-17 |
Irm Llc |
Compounds and compositions as c-kit and pdgfr kinase inhibitors
|
|
DE102007025717A1
(de)
|
2007-06-01 |
2008-12-11 |
Merck Patent Gmbh |
Arylether-pyridazinonderivate
|
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
CA2692945A1
(en)
|
2007-07-09 |
2009-01-15 |
Astrazeneca Ab |
Compounds - 945
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン，インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
JP5241834B2
(ja)
|
2007-07-19 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
プロテインキナーゼ阻害剤としての複素環アミド化合物
|
|
PH12013501594A1
(en)
|
2007-07-20 |
2014-05-12 |
Nerviano Medical Sciences Srl |
Substituted indazole derivatives active as kinase inhibitors
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
MX2010004494A
(es)
|
2007-10-23 |
2010-08-30 |
Novartis Ag |
Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
|
|
JP5400791B2
(ja)
|
2007-12-04 |
2014-01-29 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ジヒドロプテリジン−６−オン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
|
|
CA2712298C
(en)
|
2008-01-17 |
2015-11-24 |
Irm Llc |
Improved anti-trkb antibodies
|
|
EP2254886B1
(en)
|
2008-03-28 |
2016-05-25 |
Nerviano Medical Sciences S.r.l. |
3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US8426424B2
(en)
|
2008-05-06 |
2013-04-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
WO2009142732A2
(en)
|
2008-05-20 |
2009-11-26 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
GEP20125502B
(en)
|
2008-05-23 |
2012-04-25 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
|
US8119637B2
(en)
|
2008-06-10 |
2012-02-21 |
Plexxikon Inc. |
Substituted pyrrolo[2,3-b]pyrazines and methods for kinase modulation, and indications therefor
|
|
TWI546290B
(zh)
|
2008-06-27 |
2016-08-21 |
賽基艾維洛米斯研究股份有限公司 |
雜芳基化合物及其用途
|
|
JP2010013369A
(ja)
|
2008-07-01 |
2010-01-21 |
Astellas Pharma Inc |
ピラジン誘導体の製造法
|
|
US8946226B2
(en)
|
2008-07-29 |
2015-02-03 |
Nerviano Medical Sciences S.R.L. |
Use of CDK inhibitor for the treatment of glioma
|
|
AU2009279936A1
(en)
|
2008-08-05 |
2010-02-11 |
Banyu Pharmaceutical Co., Ltd. |
Therapeutic compounds
|
|
WO2010031816A1
(en)
|
2008-09-19 |
2010-03-25 |
Nerviano Medical Sciences S.R.L. |
3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
|
|
PT2350075E
(pt)
|
2008-09-22 |
2014-06-09 |
Array Biopharma Inc |
Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase
|
|
AR074052A1
(es)
|
2008-10-22 |
2010-12-22 |
Array Biopharma Inc |
Compuestos pirazolo{1,5-a}pirimidina sustituida como inhibidores de trk cinasa
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
JP2012509859A
(ja)
|
2008-11-24 |
2012-04-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
中皮腫の治療のためのｃｄｋ阻害物質
|
|
PT2370413E
(pt)
|
2008-12-08 |
2015-10-23 |
Arena Pharm Inc |
Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo
|
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
CA3121743A1
(en)
|
2009-01-15 |
2010-07-22 |
Incyte Holdings Corporation |
Processes for preparing jak inhibitors and related intermediate compounds
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
SG176111A1
(en)
|
2009-05-22 |
2011-12-29 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
ES2570756T3
(es)
|
2009-06-15 |
2016-05-20 |
Nerviano Medical Sciences Srl |
Derivados pirimidinilpirrolopiridinona sustituidos, proceso para su preparación y su uso como inhibidores de cinasa
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
EP2475375A4
(en)
|
2009-09-09 |
2013-02-20 |
Avila Therapeutics Inc |
PI3 KINASE INHIBITORS AND USES THEREOF
|
|
KR101921850B1
(ko)
|
2009-10-09 |
2018-11-23 |
인사이트 홀딩스 코포레이션 |
3-（4-（7Ｈ-피롤로〔2,3-ｄ〕피리미딘-4-일）-1Ｈ-피라졸-1-일）-3-사이클로펜틸프로판니트릴의 하이드록실, 케토 및 글루쿠로나이드 유도체
|
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
EP2528918B1
(en)
|
2010-01-29 |
2014-09-10 |
Nerviano Medical Sciences S.r.l. |
6,7-dihydroimidazo[1,5-a]pyrazin-8(5h)-one derivatives as protein kinase modulators
|
|
ES2594927T3
(es)
|
2010-02-18 |
2016-12-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Métodos para prevenir las metástasis cancerosas
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
GB201007286D0
(en)
*
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
NZ604708A
(en)
|
2010-05-20 |
2015-05-29 |
Array Biopharma Inc |
Macrocyclic compounds as trk kinase inhibitors
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
|
ES2602791T3
(es)
|
2011-01-26 |
2017-02-22 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirrolo tricíclicos, proceso para su preparación y su uso como inhibidores de cinasa
|
|
US8916577B2
(en)
|
2011-01-26 |
2014-12-23 |
Nerviano Medical Sciences S.R.L. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
KR101911972B1
(ko)
|
2011-02-07 |
2018-10-25 |
플렉시콘 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
|
|
JP5620417B2
(ja)
|
2011-02-07 |
2014-11-05 |
中外製薬株式会社 |
アミノピラゾール誘導体を含む医薬
|
|
WO2012113774A1
(en)
|
2011-02-24 |
2012-08-30 |
Nerviano Medical Sciences S.R.L. |
Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
|
|
WO2012116217A1
(en)
|
2011-02-25 |
2012-08-30 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
WO2012139930A1
(en)
|
2011-04-11 |
2012-10-18 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
CN103502241B
(zh)
|
2011-04-19 |
2016-03-23 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的取代的嘧啶基-吡咯类活性剂
|
|
KR101953272B1
(ko)
|
2011-05-12 |
2019-02-28 |
네르비아노 메디칼 사이언시스 에스.알.엘. |
키나제 억제제로서 활성인 치환된 인다졸 유도체
|
|
AU2012256237B2
(en)
|
2011-05-13 |
2017-01-05 |
Array Biopharma Inc. |
Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as TrkA kinase inhibitors
|
|
JP6016915B2
(ja)
|
2011-07-28 |
2016-10-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール
|
|
EP2740803A4
(en)
|
2011-08-05 |
2015-03-25 |
Astellas Pharma Inc |
METHOD FOR RECOGNIZING NEW FGFR4 MUTANTS
|
|
CN103748088A
(zh)
|
2011-08-17 |
2014-04-23 |
弗·哈夫曼-拉罗切有限公司 |
酪氨酸激酶抑制剂
|
|
EP2788350B1
(en)
|
2011-10-07 |
2017-12-06 |
Nerviano Medical Sciences S.r.l. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
US9145418B2
(en)
|
2011-10-07 |
2015-09-29 |
Nerviano Medical Sciences S.R.L. |
Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors
|
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118654D0
(en)
*
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2013067264A1
(en)
|
2011-11-03 |
2013-05-10 |
Genentech, Inc. |
8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
|
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
|
AU2012339753A1
(en)
|
2011-11-14 |
2014-06-19 |
Tesaro, Inc. |
Modulating certain tyrosine kinases
|
|
US9133328B2
(en)
|
2011-12-12 |
2015-09-15 |
Sa Des Eaux Minerales D'evian Saeme |
Plastic compositions and containers made thereof
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
HUE053994T2
(hu)
|
2012-03-01 |
2021-08-30 |
Array Biopharma Inc |
Szerin/treonin kináz inhibitorok
|
|
TW201350479A
(zh)
|
2012-04-26 |
2013-12-16 |
Ono Pharmaceutical Co |
Ｔｒｋ阻害化合物
|
|
US9254288B2
(en)
|
2012-05-07 |
2016-02-09 |
The Translational Genomics Research Institute |
Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
|
|
EP2855460B1
(en)
|
2012-05-23 |
2017-11-08 |
Nerviano Medical Sciences S.r.l. |
Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
ES2704744T3
(es)
|
2012-06-13 |
2019-03-19 |
Incyte Holdings Corp |
Compuestos tricíclicos sustituidos como inhibidores de FGFR
|
|
SMT202100451T1
(it)
|
2012-07-11 |
2021-09-14 |
Blueprint Medicines Corp |
Inibitori del recettore di crescita dei fibroblasti
|
|
CA2878183A1
(en)
|
2012-07-27 |
2014-01-30 |
Genentech, Inc. |
Methods of treating fgfr3 related conditions
|
|
DK2880025T3
(en)
|
2012-08-02 |
2019-03-18 |
Nerviano Medical Sciences Srl |
SUBSTITUTED PYROLES ACTIVE AS KINase INHIBITORS
|
|
CA2890346A1
(en)
|
2012-11-05 |
2014-05-08 |
Foundation Medicine, Inc. |
Novel fusion molecules and uses thereof
|
|
US9604980B2
(en)
|
2012-11-07 |
2017-03-28 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
HRP20161613T1
(hr)
|
2012-11-13 |
2017-01-13 |
Array Biopharma, Inc. |
Tvari bicikličke ureje, tioureje, gvanidina i cijanogvanidina korisne za liječenje boli
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9790210B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
MY178262A
(en)
|
2012-11-13 |
2020-10-07 |
Array Biopharma Inc |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
CN104822390A
(zh)
|
2012-11-29 |
2015-08-05 |
耶达研究及发展有限公司 |
预防肿瘤转移、癌症治疗和预后及鉴定为推定转移抑制剂的试剂的方法
|
|
EP2945652B1
(en)
|
2013-01-18 |
2021-07-07 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
|
EP2953944B1
(en)
|
2013-02-07 |
2017-04-26 |
Merck Patent GmbH |
Pyridazinone-amides derivatives
|
|
MX362181B
(es)
|
2013-02-19 |
2019-01-08 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
|
KR20150123250A
(ko)
|
2013-03-06 |
2015-11-03 |
제넨테크, 인크. |
암 약물 내성의 치료 및 예방 방법
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
|
US9850038B2
(en)
|
2013-03-15 |
2017-12-26 |
Reynolds Presto Products Inc. |
Child resistant zipper closure for recloseable pouch with double slider and methods
|
|
US8957080B2
(en)
|
2013-04-09 |
2015-02-17 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
EP2997030B1
(en)
|
2013-05-14 |
2017-08-09 |
Nerviano Medical Sciences S.R.L. |
Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
|
|
EP3004060B1
(en)
|
2013-05-30 |
2019-11-27 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
RU2016101548A
(ru)
|
2013-07-03 |
2017-08-08 |
Ф. Хоффманн-Ля Рош Аг |
Соединения амидов гетероарилпиридона и азапиридона
|
|
WO2015008844A1
(ja)
|
2013-07-18 |
2015-01-22 |
大鵬薬品工業株式会社 |
Ｆｇｆｒ阻害剤耐性癌の治療薬
|
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
EP3027654B1
(en)
|
2013-07-30 |
2019-09-25 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
|
AU2014308616B2
(en)
|
2013-08-23 |
2018-12-06 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
US10323285B2
(en)
|
2013-09-09 |
2019-06-18 |
Nantomics, Llc |
Proteomics analysis and discovery through DNA and RNA sequencing, systems and methods
|
|
KR101879422B1
(ko)
|
2013-09-18 |
2018-07-17 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물
|
|
KR20220019839A
(ko)
|
2013-10-08 |
2022-02-17 |
다이이찌 산쿄 가부시키가이샤 |
항 fgfr2 항체와 타제의 조합
|
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
MX365614B
(es)
|
2013-10-17 |
2019-06-07 |
Blueprint Medicines Corp |
Composiciones utiles para tratar trastornos relacionados con kit.
|
|
CA2928042C
(en)
|
2013-10-25 |
2022-05-10 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
|
WO2015082583A1
(en)
|
2013-12-05 |
2015-06-11 |
F. Hoffmann-La Roche Ag |
Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
|
|
JP2016539970A
(ja)
|
2013-12-09 |
2016-12-22 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害薬として有用なジヒドロピリジノンおよびジヒドロピリダジノン誘導体
|
|
CN104946737B
(zh)
|
2013-12-11 |
2019-02-22 |
安可济控股有限公司 |
用于检测罕见序列变体的组合物和方法
|
|
US10391081B2
(en)
|
2013-12-27 |
2019-08-27 |
Chugai Seiyaku Kabushiki Kaisha |
FGFR gatekeeper mutant gene and drug targeting same
|
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
|
CN103772352B
(zh)
|
2014-01-16 |
2017-01-18 |
四川百利药业有限责任公司 |
哒嗪酮类衍生物及其制备方法和用途
|
|
PL3636649T3
(pl)
|
2014-01-24 |
2024-05-06 |
Turning Point Therapeutics, Inc. |
Diaryle makrocykliczne jako modulatory kinaz białkowych
|
|
US20160340742A1
(en)
|
2014-02-04 |
2016-11-24 |
Mayo Foundation For Medical Education And Research |
Method of Identifying Tyrosine Kinase Receptor Rearrangements in Patients
|
|
MX369369B
(es)
|
2014-02-07 |
2019-11-06 |
Principia Biopharma Inc |
Derivados de quinolona como inhibidores del receptor del factor de crecimiento de fibroblastos.
|
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
|
JP6752715B2
(ja)
|
2014-03-26 |
2020-09-09 |
アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ |
組合せ
|
|
JO3512B1
(ar)
*
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
SG11201607772WA
(en)
|
2014-03-31 |
2016-10-28 |
Debiopharm Int Sa |
Fgfr fusions
|
|
WO2015160636A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
|
EP3131896B1
(en)
|
2014-04-16 |
2019-01-30 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
|
US20170044622A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
|
WO2015161277A1
(en)
|
2014-04-18 |
2015-10-22 |
Blueprint Medicines Corporation |
Met fusions
|
|
CA2949160C
(en)
|
2014-05-15 |
2023-03-21 |
Array Biopharma Inc. |
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
|
|
EA028614B1
(ru)
|
2014-05-22 |
2017-12-29 |
Общество С Ограниченной Ответственностью "Русские Фармацевтические Технологии" |
Селективные ингибиторы, нарушающие взаимодействие рецептора фактора роста фибробластов и frs2, для профилактики и лечения рака
|
|
WO2015191667A1
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Pkn1 fusions
|
|
US10378063B2
(en)
|
2014-06-10 |
2019-08-13 |
Blueprint Medicines Corporation |
RAF1 fusions
|
|
US9949971B2
(en)
|
2014-06-17 |
2018-04-24 |
Acerta Pharma B.V. |
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
|
|
WO2016011141A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Fgr fusions
|
|
EP3169809B1
(en)
|
2014-07-17 |
2020-04-29 |
Blueprint Medicines Corporation |
Prkc fusions
|
|
US10370723B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
TERT fusions
|
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
TWI573794B
(zh)
|
2014-08-18 |
2017-03-11 |
小野藥品工業股份有限公司 |
ＴｒＫ阻礙化合物之酸附加鹽
|
|
CN107427524A
(zh)
|
2014-08-28 |
2017-12-01 |
翁科埃斯克斯有限公司 |
利用包含噻吩并三唑并二氮杂*化合物的药物组合物治疗急性髓细胞白血病或急性淋巴性白血病的方法
|
|
US10167279B2
(en)
|
2014-09-12 |
2019-01-01 |
Novartis Ag |
Compounds and compositions as RAF kinase inhibitors
|
|
ES2792036T3
(es)
|
2014-11-14 |
2020-11-06 |
Nerviano Medical Sciences Srl |
Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de cinasa
|
|
HUE061448T2
(hu)
|
2014-11-16 |
2023-07-28 |
Array Biopharma Inc |
(S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid-hidrogénszulfát kristályos formája
|
|
EP3221700B1
(en)
|
2014-11-18 |
2022-06-22 |
Blueprint Medicines Corporation |
Prkacb fusions
|
|
JP2018027019A
(ja)
|
2014-11-26 |
2018-02-22 |
国立研究開発法人国立がん研究センター |
胆道がんにおける新規治療標的融合遺伝子
|
|
WO2016105503A1
(en)
|
2014-12-24 |
2016-06-30 |
Genentech, Inc. |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
US9909016B2
(en)
|
2015-02-28 |
2018-03-06 |
Matthew Fontaine |
Elastomeric coating composition
|
|
EP3265462A1
(en)
|
2015-03-03 |
2018-01-10 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Fgfr3 antagonists
|
|
US10538517B2
(en)
|
2015-05-22 |
2020-01-21 |
Principia Biopharma, Inc. |
Quinolone derivatives as FGFR inhibitors
|
|
EP3355808B1
(en)
|
2015-10-02 |
2022-11-16 |
Flexdex, Inc. |
Handle mechanism providing unlimited roll
|
|
AU2016341445B2
(en)
|
2015-10-23 |
2020-08-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
|
US9640210B1
(en)
|
2015-11-13 |
2017-05-02 |
Kabushiki Kaisha Toshiba |
Virtual window mode for guide spiral servo demodulation
|
|
US10744139B2
(en)
|
2016-09-01 |
2020-08-18 |
Nanjing Transthera Biosciences Co. Ltd. |
Inhibitors of fibroblast growth factor receptor and use thereof
|
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
|
CN108082275B
(zh)
|
2016-11-23 |
2021-08-24 |
操纵技术Ip控股公司 |
电动转向系统
|
|
DK3524603T3
(da)
|
2016-12-19 |
2022-07-04 |
Abbisko Therapeutics Co Ltd |
Fgfr4-hæmmer, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf
|
|
CN108456163A
(zh)
|
2017-02-20 |
2018-08-28 |
中国科学院上海药物研究所 |
含邻氨基杂芳环炔基的化合物及其制备方法和用途
|
|
MA47408B1
(fr)
*
|
2017-12-20 |
2023-08-31 |
Janssen Pharmaceutica Nv |
Traitement du cancer
|